Biomerica Statistics Share Statistics Biomerica has 2.55M
shares outstanding. The number of shares has increased by 4.23%
in one year.
Shares Outstanding 2.55M Shares Change (YoY) 4.23% Shares Change (QoQ) 4.23% Owned by Institutions (%) 0.69% Shares Floating 2.3M Failed to Deliver (FTD) Shares 670 FTD / Avg. Volume 0.09%
Short Selling Information The latest short interest is 427.73K, so 16.8% of the outstanding
shares have been sold short.
Short Interest 427.73K Short % of Shares Out 16.8% Short % of Float 17.87% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.41 and the forward
PE ratio is null.
Biomerica's PEG ratio is
0.
PE Ratio -1.41 Forward PE n/a PS Ratio 1.32 Forward PS n/a PB Ratio 1.71 P/FCF Ratio -1.81 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Biomerica.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.8,
with a Debt / Equity ratio of 0.11.
Current Ratio 2.8 Quick Ratio 1.95 Debt / Equity 0.11 Debt / EBITDA -0.1 Debt / FCF -0.12 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $82.98K Profits Per Employee $-77.7K Employee Count 64 Asset Turnover 0.89 Inventory Turnover 3.23
Taxes Income Tax 1K Effective Tax Rate -0.02%
Stock Price Statistics The stock price has increased by -6.25% in the
last 52 weeks. The beta is 0.26, so Biomerica's
price volatility has been higher than the market average.
Beta 0.26 52-Week Price Change -6.25% 50-Day Moving Average 3.27 200-Day Moving Average 3.75 Relative Strength Index (RSI) 38.94 Average Volume (20 Days) 710,330
Income Statement In the last 12 months, Biomerica had revenue of 5.31M
and earned -4.97M
in profits. Earnings per share was -2.16.
Revenue 5.31M Gross Profit 498K Operating Income -5.14M Net Income -4.97M EBITDA -4.74M EBIT -5.14M Earnings Per Share (EPS) -2.16
Full Income Statement Balance Sheet The company has 2.4M in cash and 458K in
debt, giving a net cash position of 1.94M.
Cash & Cash Equivalents 2.4M Total Debt 458K Net Cash 1.94M Retained Earnings -53.17M Total Assets 5.95M Working Capital 3.13M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -3.84M
and capital expenditures -37K, giving a free cash flow of -3.88M.
Operating Cash Flow -3.84M Capital Expenditures -37K Free Cash Flow -3.88M FCF Per Share -1.69
Full Cash Flow Statement Margins Gross margin is 9.38%, with operating and profit margins of -96.72% and -93.64%.
Gross Margin 9.38% Operating Margin -96.72% Pretax Margin -93.62% Profit Margin -93.64% EBITDA Margin -89.19% EBIT Margin -96.72% FCF Margin -73.02%
Dividends & Yields BMRA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for BMRA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 21, 2025. It was a
backward
split with a ratio of 1:8.
Last Split Date Apr 21, 2025 Split Type backward Split Ratio 1:8
Scores Altman Z-Score -11.35 Piotroski F-Score 3
